-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Regulus Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Regulus Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.2M, a 87.2% decline year-over-year.
- Regulus Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$44.6M, a 49.9% decline year-over-year.
- Regulus Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$31.1M, a 10.2% decline from 2022.
- Regulus Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$28.2M, a 1.52% decline from 2021.
- Regulus Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$27.8M, a 96.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)